Formulating protein therapeutics into particulate forms
Authors:
- 10 August 2009
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Delivery
- Vol. 6 (10) , 1123-1133
Abstract
(2009). Formulating protein therapeutics into particulate forms. Expert Opinion on Drug Delivery: Vol. 6, No. 10, pp. 1123-1133. doi: 10.1517/17425240903156374Keywords
This publication has 59 references indexed in Scilit:
- Formulating erythropoietin-loaded sustained-release PLGA microspheres without protein aggregationJournal of Controlled Release, 2008
- Preparing polymer-based sustained-release systems without exposing proteins to water–oil or water–air interfaces and cross-linking reagentsJournal of Controlled Release, 2008
- Nanoparticles: Characteristics, Mechanisms of Action, and Toxicity in Pulmonary Drug Delivery—A ReviewJournal of Biomedical Nanotechnology, 2007
- Novel Long-Acting Crystal Formulation of Human Growth HormonePharmaceutical Research, 2005
- Trojan particles: Large porous carriers of nanoparticles for drug deliveryProceedings of the National Academy of Sciences, 2002
- Controlled Release of Interleukin-2 from Chitosan MicrospheresJournal of Pharmaceutical Sciences, 2002
- Protein encapsulation into biodegradable microspheres by a novel S/O/W emulsion method using poly(ethylene glycol) as a protein micronization adjuvantJournal of Controlled Release, 2000
- Biodegradable block copolymers as injectable drug-delivery systemsNature, 1997
- Protein Delivery from Biodegradable Microspheres1996
- Controlled Release of Interleukin-2 from Biodegradable MicrospheresNature Biotechnology, 1990